Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Svane

Showing results (721-730 of 811) with videos related to

Pageof 82
Sort By:
Lab on a Chip|October 26, 2018
Diagnosis of traumatic brain injury using miRNA signatures in nanomagnetically isolated brain-derived extracellular vesiclesJ Ko, M Hemphill, Z Yang, et al.
American Journal of Industrial Medicine|December 21, 2002
Performance of different exposure assessment approaches in a study of bitumen fume exposure and lung cancer mortalityIgor Burstyn, Paolo Boffetta, Timo Kauppinen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 3, 2014
Antibody stabilization of peptide-MHC multimers reveals functional T cells bearing extremely low-affinity TCRsKatie Tungatt, Valentina Bianchi, Michael D Crowther, et al.
Oncoimmunology|December 8, 2018
Adoptive cell therapy with tumor-infiltrating lymphocytes in patients with metastatic ovarian cancer: a pilot studyMagnus Pedersen, Marie Christine Wulff Westergaard, Katy Milne, et al.
Frontiers in Immunology|November 26, 2020
Peptide Vaccination Against PD-L1 With IO103 a Novel Immune Modulatory Vaccine in Multiple Myeloma: A Phase I First-in-Human TrialNicolai Grønne Jørgensen, Uffe Klausen, Jacob Handlos Grauslund, et al.
Cancers|December 23, 2020
Changes in the Tumor Immune Microenvironment during Disease Progression in Patients with Ovarian CancerMarie Christine Wulff Westergaard, Katy Milne, Magnus Pedersen, et al.
Neurogastroenterology and Motility|August 11, 2021
Neurotensin secretion after Roux-en-Y gastric bypass, sleeve gastrectomy, and truncal vagotomy with pyloroplastyMaria S Svane, Caroline C Øhrstrøm, Astrid Plamboeck, et al.
Cancer Immunology Research|June 17, 2024
Nivolumab Reaches Brain Lesions in Patients with Recurrent Glioblastoma and Induces T-cell Activity and Upregulation of Checkpoint PathwaysSigne K Skadborg, Simone Maarup, Arianna Draghi, et al.
International Journal of Obesity (2005)|August 18, 2022
Four weeks treatment with the GLP-1 receptor analogue liraglutide lowers liver fat and concomitantly circulating glucagon in individuals with overweightMaria S Svane, Helle H Johannesen, Adam E Hansen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2019
Evaluation of Two Dosing Regimens for Nivolumab in Combination With Ipilimumab in Patients With Advanced Melanoma: Results From the Phase IIIb/IV CheckMate 511 TrialCeleste Lebbé, Nicolas Meyer, Laurent Mortier, et al.
Pageof 82

Showing results (721-730 of 811) with videos related to

Sort By:
Pageof 82
Lab on a Chip|October 26, 2018
Diagnosis of traumatic brain injury using miRNA signatures in nanomagnetically isolated brain-derived extracellular vesiclesJ Ko, M Hemphill, Z Yang, et al.
American Journal of Industrial Medicine|December 21, 2002
Performance of different exposure assessment approaches in a study of bitumen fume exposure and lung cancer mortalityIgor Burstyn, Paolo Boffetta, Timo Kauppinen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 3, 2014
Antibody stabilization of peptide-MHC multimers reveals functional T cells bearing extremely low-affinity TCRsKatie Tungatt, Valentina Bianchi, Michael D Crowther, et al.
Oncoimmunology|December 8, 2018
Adoptive cell therapy with tumor-infiltrating lymphocytes in patients with metastatic ovarian cancer: a pilot studyMagnus Pedersen, Marie Christine Wulff Westergaard, Katy Milne, et al.
Frontiers in Immunology|November 26, 2020
Peptide Vaccination Against PD-L1 With IO103 a Novel Immune Modulatory Vaccine in Multiple Myeloma: A Phase I First-in-Human TrialNicolai Grønne Jørgensen, Uffe Klausen, Jacob Handlos Grauslund, et al.
Cancers|December 23, 2020
Changes in the Tumor Immune Microenvironment during Disease Progression in Patients with Ovarian CancerMarie Christine Wulff Westergaard, Katy Milne, Magnus Pedersen, et al.
Neurogastroenterology and Motility|August 11, 2021
Neurotensin secretion after Roux-en-Y gastric bypass, sleeve gastrectomy, and truncal vagotomy with pyloroplastyMaria S Svane, Caroline C Øhrstrøm, Astrid Plamboeck, et al.
Cancer Immunology Research|June 17, 2024
Nivolumab Reaches Brain Lesions in Patients with Recurrent Glioblastoma and Induces T-cell Activity and Upregulation of Checkpoint PathwaysSigne K Skadborg, Simone Maarup, Arianna Draghi, et al.
International Journal of Obesity (2005)|August 18, 2022
Four weeks treatment with the GLP-1 receptor analogue liraglutide lowers liver fat and concomitantly circulating glucagon in individuals with overweightMaria S Svane, Helle H Johannesen, Adam E Hansen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2019
Evaluation of Two Dosing Regimens for Nivolumab in Combination With Ipilimumab in Patients With Advanced Melanoma: Results From the Phase IIIb/IV CheckMate 511 TrialCeleste Lebbé, Nicolas Meyer, Laurent Mortier, et al.
Pageof 82